- Statutory Instrument 1999 No. 784
The Medicines (Monitoring of Advertising) Amendment Regulations 1999
© Crown Copyright 1999
Statutory Instruments printed from this website are printed under the superintendence and authority of the Controller of HMSO being the Queen's Printer of Acts of Parliament.
The legislation contained on this web site is subject to Crown Copyright protection. It may be reproduced free of charge provided that it is reproduced accurately and that the source and copyright status of the material is made evident to users.
It should be noted that the right to reproduce the text of Statutory Instruments does not extend to the Queen's Printer imprints which should be removed from any copies of the Statutory Instrument which are issued or made available to the public. This includes reproduction of the Statutory Instrument on the Internet and on intranet sites. The Royal Arms may be reproduced only where they are an integral part of the original document.
The text of this Internet version of the Statutory Instrument which is published by the Queen's Printer of Acts of Parliament has been prepared to reflect the text as it was Made. A print version is also available and is published by The Stationery Office Limited as the The Medicines (Monitoring of Advertising) Amendment Regulations 1999 , ISBN 0 11 082246 3. The print version may be purchased by clicking here. Braille copies of this Statutory Instrument can also be purchased at the same price as the print edition by contacting TSO Customer Services on 0870 600 5522 or e-mail:customer.services@tso.co.uk.
Further information about the publication of legislation on this website can be found by referring to the Frequently Asked Questions.
To ensure fast access over slow connections, large documents have been segmented into "chunks". Where you see a "continue" button at the bottom of the page of text, this indicates that there is another chunk of text available.
This Statutory Instrument has been printed to correct an error in S.I. 1999/267 and is being issued free of charge to all known recipients of that Statutory Instrument
| Made | 9th March 1999 | ||
| Laid before Parliament | 15th March 1999 | ||
| Coming into force | 5th April 1999, in accordance with regulation 1 |
The Secretary of State, being a Minister designated for the purposes of section 2(2) of the European Communities Act 1972[1] in relation to medicinal products[2], in exercise of the powers conferred on him by the said section 2(2), and the Secretaries of State respectively concerned with health in England, in Wales and in Scotland and the Department of Health and Social Services for Northern Ireland, acting jointly, in exercise of the powers conferred upon them by sections 95(1) and (6) of the Medicines Act 1968[3], or, as the case may be, powers conferred by the said provisions and now vested in them[4], and in each case of all other powers enabling them in that behalf, after consultation (in accordance with section 129(6) of the Medicines Act 1968) with such organisations as appear to them to be representative of interests likely to be substantially affected by these Regulations, hereby make the following Regulations:-
Citation ad Commencement
1. These Regulations may be cited as the Medicines (Monitoring of Advertising) Amendment Regulations 1999 and shall come into force on 5th April 1999, immediately after the Medicines (Advertising and Monitoring of Advertising) Amendment Regulations 1999[5] come into force.
Amendment of the Medicines (Monitoring of Advertising) Regulations 1991
2. In paragraph 7(a) of the Schedule to the Medicines (Monitoring of Advertising) Regulations 1994[6], for "level 5 on the standard scale" there shall be substituted "the statutory maximum".
Signed by authority of the Secretary of State for Health
Hayman
Parliamentary Under Secretary of State, Department of Health
8th March 1999
Signed by authority of the Secretary of State for Wales
Jon Owen Jones
Parliamentary Under Secretary of State, Welsh Office
9th March 1999
Signed by authority of the Secretary of State for Scotland
Sam Galbraith
Parliamentary Under Secretary of State, Scottish Office
9th March 1999
Sealed with the Official Seal of the Department of Health and Social Services for Northern Ireland on
L.S.
D. C. Gowdy
Permanent Secretary
5th March 1999.
(This note is not part of the Regulations)
These Regulations amend paragraph 7(a) of the Schedule to the Medicines (Monitoring of Advertising) Regulations 1994 (S.I. 1994/1933), as inserted by the Medicines (Advertising and Monitoring of Advertising) Amendment Regulations 1999 (S.I. 1999/267), in order to clarify the maximum penalty available on summary conviction of the either way offence referred to in paragraph 7.
Notes:
[1] 1972 c. 68.back
[3] 1968 c. 67; see section 1(2)(a) of the 1968 Act, which contains a definition of "the appropriate Ministers" which is relevant to the powers being exercised in the making of these Regulations.back
[4] In the case of the Secretaries of State concerned with health in England and Wales, by virtue of article 2(2) of, and Schedule 1 to, the Transfer of Functions (Wales) Order 1969; and in the case of the Department of Health and Social Services for Northern Ireland, by virtue of section 40 of, and Schedule 5 to, the Northern Ireland Constitution Act 1973 (c. 36) and section 1(3) of, and paragraph 2(1)(b) of Schedule 1 to, the Northern Ireland Act 1974 (c. 28).back
[6] S.I. 1994/1933; the Schedule was inserted by S.I. 1999/267.back
ISBN 0 11 082246 3